Novo Resources Corp. announced a webinar on May 1, 2026, where Executive Co-Chairman Mike Spreadborough will discuss the company's March quarter activities and future outlook. The company focuses on gold and copper exploration in Australia, with key projects in the Pilbara region and New South Wales. The webinar will cover ongoing exploration efforts, including drilling programs and joint ventures, and will include a Q&A session. This event provides investors insight into Novo's strategic progress and exploration plans.
The European Commission has approved Novo Nordisk's Wegovy pill, the first oral GLP-1 receptor agonist for weight management across the EU. This approval covers adults with obesity or overweight with related health issues and follows positive clinica...
The global blood glucose monitoring system market, valued at $16.8 billion in 2025, is projected to grow to $39.4 billion by 2035 at an 8.9% CAGR. Growth is fueled by rising diabetes prevalence, advancements in AI-enabled monitoring devices, and incr...
Vivani Medical is developing a semaglutide implant aimed at improving long-term adherence to GLP-1 treatments like Wegovy and Ozempic, which help with obesity and diabetes. The implant, designed to be replaced biannually or annually, could reduce sid...
